CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for MOLOGEN Lifescience AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

MOLOGEN Lifescience AG
Johnsallee 30
Phone: +49 4042236668p:+49 4042236668 HAMBURG, 20148  Germany Ticker: U1DAU1DA
Business Summary
MOLOGEN Lifescience AG, formerly Finchain Capital Partners AG, is a Germany-based company. The Company is in the development, manufacturing, acquisition, licensing, distribution, and marketing of products, processes, and services in the fields of life sciences, biotechnology, medical technology, healthcare, and pharmaceuticals. In addition, the Company is engaged in the research, development, production, and commercialization of biotechnological technologies and active ingredients, including but not limited to nanotechnology and microbiological systems, as well as activated vesicle technologies and their application in dietary supplements, cosmetic products, medical preparations, and therapeutic procedures. It operates pharmaceutical facilities, in particular mail-order pharmacies, manufacturing facilities, cleanroom laboratories, and other laboratory and diagnostic facilities.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2021Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Supervisory Board MartinUzik
Deputy Chairman of the Supervisory Board WolfgangSiewering
Member of the Management Board NorbertSchmidt 12/1/2020 12/1/2020
Member of the Management Board ChristianSchmitz 62 2/1/2021 2/1/2021
Member of the Supervisory Board UweHeller

Business Names
Business Name
U1D
U1DA

General Information
Outstanding Shares: 1,378,750 (As of 12/22/2025)
Stock Exchange: FRA
Fax Number: +49 4035676419


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, May 30, 2026